Latest News for: fibroblast growth factor receptor 3

Edit

AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR BEMARITUZUMAB IN FIBROBLAST GROWTH FACTOR RECEPTOR 2b ...

Fairbanks Daily News-Miner 01 Jul 2025
At an Interim Analysis, Bemarituzumab Plus Chemotherapy Significantly Improved Overall Survival in People With FGFR2b Overexpression Compared to Chemotherapy Alone ... .
Edit

Zai Lab Announces Positive Topline Phase 3 Results for Bemarituzumab in Fibroblast Growth Factor Receptor ...

The Eagle-Tribune 30 Jun 2025
SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun 30, 2025-- ... .
Edit

AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR BEMARITUZUMAB IN FIBROBLAST GROWTH FACTOR RECEPTOR 2b (FGFR2b) POSITIVE FIRST-LINE GASTRIC CANCER

PR Newswire 30 Jun 2025
About FGFR2b  The FGFR2b protein (also known as fibroblast growth factor receptor 2b) is an emerging biomarker which, when overexpressed, promotes aberrant signaling leading to tumor cell proliferation.2.
  • 1

Article Search

tools
×
×
×
×